223 related articles for article (PubMed ID: 31016881)
1. Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma.
Andronesi AG; Tanase AD; Sorohan BM; Craciun OG; Stefan L; Varady Z; Lipan L; Obrisca B; Truica A; Ismail G
Cancer Med; 2019 Jun; 8(6):3278-3285. PubMed ID: 31016881
[TBL] [Abstract][Full Text] [Related]
2. Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study.
Rodrigues N; Costa C; Branco C; Martins C; Lopes JA
J Nephrol; 2024 Mar; 37(2):419-428. PubMed ID: 38019417
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant predictors and posttransplant sequels of acute kidney injury after allogeneic stem cell transplantation.
Kagoya Y; Kataoka K; Nannya Y; Kurokawa M
Biol Blood Marrow Transplant; 2011 Mar; 17(3):394-400. PubMed ID: 20655388
[TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury in autologous hematopoietic stem cell transplant for patients with lymphoma - KDIGO classification with creatinine and urinary output criteria: a cohort analysis.
Rodrigues N; Branco C; Costa C; Marques F; Neves M; Vasconcelos P; Martins C; Lopes JA
Ren Fail; 2023 Dec; 45(1):2183044. PubMed ID: 36856327
[TBL] [Abstract][Full Text] [Related]
5. Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation.
Abramson MH; Gutgarts V; Zheng J; Maloy MA; Ruiz JD; Scordo M; Jaimes EA; Sathick IJ
Clin J Am Soc Nephrol; 2021 Sep; 16(9):1318-1327. PubMed ID: 34135023
[TBL] [Abstract][Full Text] [Related]
6. Hyperferritinemia and acute kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation.
Kurokawa M; Nishiyama K; Koga Y; Eguchi K; Imai T; Oba U; Shiraishi A; Nagata H; Kaku N; Ishimura M; Honjo S; Ohga S
Pediatr Nephrol; 2020 Oct; 35(10):1977-1984. PubMed ID: 32488669
[TBL] [Abstract][Full Text] [Related]
7. The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma.
Jaglowski SM; Ruppert AS; Hofmeister CC; Elder P; Blum W; Klisovic R; Vasu S; Penza S; Efebera YA; Benson DM; Devine SM; Andritsos LA
Bone Marrow Transplant; 2014 Oct; 49(10):1323-9. PubMed ID: 25068419
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Yu ZP; Ding JH; Chen BA; Liu BC; Liu H; Li YF; Ding BH; Qian J
Chin J Cancer; 2010 Nov; 29(11):946-51. PubMed ID: 20979694
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment for acute kidney injury after allogeneic hematopoietic stem cell transplantation based on Acute Kidney Injury Network criteria.
Mori J; Ohashi K; Yamaguchi T; Ando M; Hirashima Y; Kobayashi T; Kakihana K; Sakamaki H
Intern Med; 2012; 51(16):2105-10. PubMed ID: 22892486
[TBL] [Abstract][Full Text] [Related]
10. Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis.
Nader R; Zhen A; Angel-Korman A; Pavlovich SS; Pogrebinsky A; Doros G; Menn-Josephy H; Stern L; Sanchorawala V; Havasi A
Nephrol Dial Transplant; 2022 Jun; 37(7):1281-1288. PubMed ID: 34043009
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Catheter-Related Thrombosis in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.
Hoppe A; Rupa-Matysek J; Małecki B; Dytfeld D; Hoppe K; Gil L
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684057
[No Abstract] [Full Text] [Related]
12. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
[TBL] [Abstract][Full Text] [Related]
13. Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis.
Irazabal MV; Eirin A; Gertz MA; Dispenzieri A; Kumar S; Buadi FK; Lacy MQ; Hayman SR; Dingli D; Hogan WJ; Gastineau DA; Glavey SV; Amer H; Leung N
Am J Hematol; 2012 Jan; 87(1):51-4. PubMed ID: 22076913
[TBL] [Abstract][Full Text] [Related]
14. Independent risk factors and long-term outcomes for acute kidney injury in pediatric patients undergoing hematopoietic stem cell transplantation: a retrospective cohort study.
Hirano D; Kakegawa D; Miwa S; Umeda C; Takemasa Y; Tokunaga A; Kawakami Y; Ito A
BMC Nephrol; 2020 Aug; 21(1):373. PubMed ID: 32854640
[TBL] [Abstract][Full Text] [Related]
15. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma.
Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D
Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040
[TBL] [Abstract][Full Text] [Related]
16. Acute kidney injury after allogeneic hematopoietic stem cell transplantation - Predictors and survival impact: A single center retrospective study.
Menezes MDM; Marques AI; Chuva T; Pinho Vaz C; Ferreira H; Branca R; Paiva A; Campos A; Maximino Costa J
Nefrologia (Engl Ed); 2022; 42(6):656-663. PubMed ID: 36402680
[TBL] [Abstract][Full Text] [Related]
17. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
18. Urine neutrophil gelatinase associated lipocalin as an early marker of acute kidney injury in hematopoietic stem cell transplantation patients.
Taghizadeh-Ghehi M; Sarayani A; Ashouri A; Ataei S; Moslehi A; Hadjibabaie M
Ren Fail; 2015 Jul; 37(6):994-8. PubMed ID: 25945602
[TBL] [Abstract][Full Text] [Related]
19. The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation.
Fleming S; Harrison SJ; Blombery P; Joyce T; Stokes K; Seymour JF; Prince HM; Ritchie D
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):291-6. PubMed ID: 24629850
[TBL] [Abstract][Full Text] [Related]
20. Impact of Autologous Stem Cell Transplantation on Blood Pressure and Renal Function in Multiple Myeloma Patients.
Balsam L; Saad C; Arsene C; Fogel J
J Natl Med Assoc; 2017 Autumn; 109(3):182-191. PubMed ID: 28987247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
